IOVA
USDIovance Biotherapeutics Inc. Common Stock
$2.300+0.050 (2.222%)
실시간 가격
Healthcare
생명공학
미국
가격 차트
Loading Chart...
핵심 지표
시장 지표
시가
$2.250
고가
$2.380
저가
$2.080
거래량
17.39M
기업 기본 정보
시가총액
913.0M
산업
생명공학
국가
United States
거래 통계
평균 거래량
13.73M
거래소
NGM
통화
USD
52주 범위
저가 $1.64현재가 $2.300고가 $10.86
관련 뉴스
GlobeNewswire
Iovance Biotherapeutics Reports Potential Best-in-Class Clinical Data for Lifileucel TIL Cell Therapy in Advanced Non-Small Cell Lung Cancer (NSCLC)
26% Objective Response Rate Median Duration of Response Not Reached after 25 Months Follow Up Lifileucel Launch in Previously Treated Advanced NSCLC Expected in Second Half of 2027 SAN CARLOS, Calif., Nov. 03, 2025
더 보기
Analyst Upgrades
HC Wainwright & Co. Maintains Buy on Iovance Biotherapeutics, Lowers Price Target to $9
HC Wainwright & Co. analyst Joseph Pantginis maintains Iovance Biotherapeutics with a Buy and lowers the price target from $20 to $9.
더 보기
